{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:05:48Z","timestamp":1794013548709,"version":"4.8.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1053\/j.semnuclmed.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T07:27:58Z","timestamp":1664177278000},"page":"258-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["FDG PET\/CT Imaging of Sarcoidosis"],"prefix":"10.1053","volume":"53","author":[{"given":"Claudine","family":"R\u00e9gis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Benali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6109-0087","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Rouzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0001","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1378\/chest.123.5.1527","article-title":"Occupational risk factors for sarcoidosis in African-American siblings","volume":"123","author":"Kucera","year":"2003","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0002","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0003","first-page":"49","article-title":"Photocopier exposure and risk of sarcoidosis in African-American sibs","volume":"21","author":"Rybicki","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1165\/rcmb.2015-0212OC","article-title":"Molecular analysis of sarcoidosis granulomas reveals antimicrobial targets","volume":"55","author":"Rotsinger","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154716","article-title":"Immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis","volume":"11","author":"Fang","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0006","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","article-title":"Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis","volume":"40","author":"Eishi","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0007","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.semnuclmed.2018.02.005","article-title":"Nuclear Imaging in Sarcoidosis","volume":"48","author":"Piekarski","year":"2018","journal-title":"Seminars in Nuclear Medicine"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0008","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ccm.2015.08.003","article-title":"The Diagnosis of Sarcoidosis","volume":"36","author":"Govender","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00430-2019","article-title":"Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis","volume":"54","author":"Calender","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","article-title":"Mechanism of granuloma formation in sarcoidosis","volume":"24","author":"Sakthivel","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0011","series-title":"Robbins and Cotran's Pathological Basis of Disease","author":"Kumar","year":"2010"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0012","series-title":"Goldman's Cecil Medicine","article-title":"Chapter 95 - Sarcoidosis","author":"Iannuzzi","year":"2012"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1164\/rccm.200608-1197OC","article-title":"Sex-specific manifestations of l\u00f6fgren's syndrome","volume":"175","author":"Grunewald","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0014","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"Sarcoidosis. N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.11604\/pamj.2015.22.307.7515","article-title":"Le syndrome de Heerfordt","volume":"22","author":"Hammoune","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0016","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1590\/abd1806-4841.20175211","article-title":"Do you know this syndrome? Heerfordt-Waldenstr\u00f6m syndrome","volume":"92","author":"Fraga","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0017","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","article-title":"Course and prognosis of sarcoidosis around the world","volume":"57","author":"Siltzbach","year":"1974","journal-title":"Am J Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0018","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MCP.0000000000000080","article-title":"Morbidity and mortality in sarcoidosis","volume":"20","author":"Gerke","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0019","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0020","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. an official american thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1546-0096-12-33","article-title":"Blau Syndrome, the prototypic auto-inflammatory granulomatous disease","volume":"12","author":"Wouters","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0022","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/1744666X.2019.1568240","article-title":"Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis","volume":"15","author":"Ramos-Casals","year":"2019","journal-title":"Expert Review of Clinical Immunology"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0023","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ebiom.2016.04.024","article-title":"Diagnostic Performance of bronchoalveolar lavage fluid CD4\/CD8 ratio for sarcoidosis: a meta-analysis","volume":"8","author":"Shen","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0024","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2009.04.010","article-title":"Hypothesis: sarcoidosis is a STAT1-mediated disease","volume":"132","author":"Rosenbaum","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0026","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jdcr.2019.02.006","article-title":"Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera","volume":"5","author":"Wei","year":"2019","journal-title":"JAAD Case Reports"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0027","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaad.2019.05.098","article-title":"Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare","volume":"82","author":"Damsky","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0028","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0029","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","article-title":"Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis","volume":"379","author":"Damsky","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0030","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1536\/ihj.21-164","article-title":"Cytokine signaling and matrix remodeling pathways associated with cardiac sarcoidosis disease activity defined using FDG-PET imaging","volume":"62","author":"Young","year":"2021","journal-title":"Int Heart J"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0031","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/jdv.13246","article-title":"TNF-\u03b1: a treatment target or cause of sarcoidosis?","volume":"29","author":"Amber","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0032","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1183\/09031936.00169413","article-title":"Association of the TNF-\u03b1 G-308A polymorphism with TNF-inhibitor response in sarcoidosis","volume":"43","author":"Wijnen","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0033","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: A significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am J Human Genetics"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0034","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","volume":"18","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.clindermatol.2007.03.009","article-title":"Radiological manifestations of sarcoidosis","volume":"25","author":"Vagal","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0036","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5578\/ttj.17.1.004","article-title":"The role of endobronchial biopsy in the diagnosis of pulmonary sarcoidosis","volume":"17","author":"G\u00f6ktalay","year":"2016","journal-title":"Turk Thorac J"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0037","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England","volume":"2","author":"Scadding","year":"1961","journal-title":"Br Med J"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0038","first-page":"1371","volume":"136","author":"Polychronopoulos","year":"2009","journal-title":"Airway Involvement in Sarcoidosis. Chest"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0039","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/17476348.2016.1164602","article-title":"Clinical management of pulmonary sarcoidosis","volume":"10","author":"Zhou","year":"2016","journal-title":"Expert Review of Respiratory Medicine"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0040","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1148\/rg.306105512","article-title":"Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation","volume":"30","author":"Criado","year":"2010","journal-title":"RadioGraphics"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0041","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1148\/rg.2018170157","article-title":"Sarcoidosis from Head to Toe: What the Radiologist Needs to Know","volume":"38","author":"Ganeshan","year":"2018","journal-title":"RadioGraphics"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0042","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1007\/s00330-015-3685-4","article-title":"Chest Computed Tomography-Based Scoring of Thoracic Sarcoidosis: Inter-rater Reliability of CT Abnormalities","volume":"25","author":"Van den Heuvel","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0043","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0044","first-page":"66","article-title":"Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG-PET","volume":"55","author":"Keijsers","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0045","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00259-008-0770-9","article-title":"18F-FDG-PET\/CT in sarcoidosis management: review and report of 20 cases","volume":"35","author":"Braun","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0046","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188 Whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis","volume":"132","author":"Teirstein","year":"2007","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0047","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0048","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/RLU.0b013e31827a27df","article-title":"18F-FDG-PET\/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study","volume":"38","author":"Ambrosini","year":"2013","journal-title":"Clinical Nuclear Medicine"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0049","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/bjophthalmol-2018-313133","article-title":"18F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan","volume":"103","author":"Chauvelot","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.rmed.2012.11.011","article-title":"Severity of pulmonary involvement and (18)F-FDG-PET activity in sarcoidosis","volume":"107","author":"Mostard","year":"2013","journal-title":"Respir Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0051","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0052","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.ejrad.2013.08.019","article-title":"Proton MRI in the evaluation of pulmonary sarcoidosis: comparison to chest CT","volume":"82","author":"Chung","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0053","first-page":"PA3820","article-title":"MR imaging of lung parenchymal changes in sarcoidosis","volume":"48","author":"Ley","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0054","first-page":"108","article-title":"Pulmonary artery 18F-fluorodeoxyglucose uptake by PET\/CMR as a marker of pulmonary hypertension in sarcoidosis","volume":"15","author":"Maier","year":"2022","journal-title":"JACC: Cardiovascular Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12410-018-9446-4","article-title":"Molecular imaging of cardiac sarcoidosis","volume":"11","author":"Martineau","year":"2018","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0056","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semnuclmed.2020.03.005","article-title":"Imaging and quantification of cardiac sarcoidosis","volume":"50","author":"Elwazir","year":"2020","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0057","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0058","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG-PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0059","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s12350-018-01582-y","article-title":"Diagnostic performance of F-18 FDG-PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0060","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s12350-019-01755-3","article-title":"Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations","volume":"26","author":"Kumita","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0061","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/ehf2.12853","article-title":"Diagnosis of isolated cardiac sarcoidosis based on new guidelines","volume":"7","author":"Kawai","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0062","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025565","article-title":"Utility of updated japanese circulation society guidelines to diagnose isolated cardiac sarcoidosis","author":"Sato","year":"2022","journal-title":"J Am Heart Assoc e025565"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0063","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI\u2013ASNC expert consensus document on the role of 18 F-FDG-PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0064","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS Expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0065","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1007\/s00259-020-04713-1","article-title":"Suppression of myocardial glucose metabolism in FDG-PET\/CT: impact of dose variation in heparin bolus pre-administration","volume":"47","author":"Scholtens","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0066","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0067","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0284185115600916","article-title":"Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart","volume":"57","author":"Masuda","year":"2016","journal-title":"Acta Radiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0068","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/s41598-021-82217-0","article-title":"Value of Patlak Ki images from 18F-FDG-PET\/CT for evaluation of the relationships between disease activity and clinical events in cardiac sarcoidosis","volume":"11","author":"Nakajo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0069","first-page":"94","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC: Cardiovascular Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0070","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00259-018-4195-9","article-title":"Use of 18F-FDG-PET\/CT texture analysis to diagnose cardiac sarcoidosis","volume":"46","author":"Manabe","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0071","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12350-019-01659-2","article-title":"FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","volume":"28","author":"Tuominen","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0072","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00259-020-05066-5","article-title":"Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM","volume":"48","author":"Slart","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0073","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/jcm9030890","article-title":"In which patients with sarcoidosis is FDG-PET\/CT indicated?","volume":"9","author":"Keijsers","year":"2020","journal-title":"J Clin Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0074","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0075","series-title":"FDG-PET is a Superior Tool in the Diagnosis and Management of Cardiac Sarcoidosis","author":"Bokhari","year":"2017"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0076","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0077","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaea97","article-title":"Correction of respiratory and cardiac motion in cardiac PET\/MR using MR-based motion modeling","volume":"63","author":"Robson","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0078","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"European Heart Journal - Cardiovascular Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0079","doi-asserted-by":"crossref","unstructured":"Trivieri MG, Robson PM, Vergani V, et al (2022) Evaluating the association between hybrid magnetic resonance positron emission tomography and cardiac-related outcomes in cardiac sarcoidosis. medRxiv 2022.01.13.22269230. doi:10.1101\/2022.01.13.22269230","DOI":"10.1101\/2022.01.13.22269230"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0080","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0081","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1007\/s12350-018-01578-8","article-title":"Same day comparison of PET\/CT and PET\/MR in patients with cardiac sarcoidosis","volume":"27","author":"Wisenberg","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0082","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12350-020-02359-y","article-title":"Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis","volume":"29","author":"Okune","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0083","first-page":"445","article-title":"Hybrid cardiac magnetic resonance\/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis","volume":"15","author":"Greulich","year":"2022","journal-title":"JACC: Cardiovascular Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0084","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/RLU.0b013e3182335f9b","article-title":"F-18 FDG-PET\/CT for detecting bone and bone marrow involvement in sarcoidosis patients","volume":"37","author":"Mostard","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0086","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/17476348.2020.1775587","article-title":"Prevalence, distribution and clinical significance of joints, muscles and bones in sarcoidosis: an 18F-FDG-PET\/CT study","volume":"14","author":"Papiris","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0087","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1007\/s10067-020-05022-6","article-title":"18F-FDG-PET\/CT in bone sarcoidosis: an observational study","volume":"39","author":"Demaria","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0088","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13244-016-0495-4","article-title":"Clinical and radiological features of extra-pulmonary sarcoidosis: a pictorial essay","volume":"7","author":"Palmucci","year":"2016","journal-title":"Insights Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0089","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1097\/RLU.0b013e318279f264","article-title":"Functional imaging in extrapulmonary sarcoidosis: FDG-PET\/CT and MR features","volume":"39","author":"Soussan","year":"2014","journal-title":"Clinical Nuclear Medicine"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/24725625.2019.1681635","article-title":"A case of L\u00f6fgren's syndrome evaluated by imaging modalities: musculoskeletal ultrasound, MRI and PET-CT","volume":"4","author":"Uchida","year":"2020","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0091","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2001-15675","article-title":"Muscular sarcoidosis","volume":"5","author":"Otake","year":"2001","journal-title":"Semin Musculoskelet Radiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0092","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/ijnm.IJNM_67_20","article-title":"Tiger man Sign-F-18 FDG-PET\/CT scan pattern in muscular and cutaneous sarcoidosis: A case report and literature survey","volume":"35","author":"Pruthi","year":"2020","journal-title":"Indian J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0093","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1093\/rheumatology\/keaa833","article-title":"Tiger man sign in sarcoid myopathy","volume":"60","author":"Kuzume","year":"2021","journal-title":"Rheumatology"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0094","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/jcm8060803","article-title":"Hybrid Imaging in Head and Neck Sarcoidosis","volume":"8","author":"Grozdic Milojevic","year":"2019","journal-title":"JCM"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ro.2004.06.006","article-title":"Neurosarcoidosis\u2014review of imaging findings","volume":"39","author":"Lury","year":"2004","journal-title":"Seminars in Roentgenology"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0096","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1148\/rg.2018180053","article-title":"PET\/CT in the diagnosis and workup of sarcoidosis: focus on atypical manifestations","volume":"38","author":"Akaike","year":"2018","journal-title":"RadioGraphics"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0097","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","article-title":"Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients","volume":"105","author":"Langrand","year":"2012","journal-title":"QJM"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0098","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00415-010-5729-7","article-title":"FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis","volume":"258","author":"Sakushima","year":"2011","journal-title":"J Neurol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0099","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.mayocp.2020.01.032","article-title":"Whole-Body 18F-FDG-PET\/CT in the diagnosis of neurosarcoidosis","volume":"95","author":"Fritz","year":"2020","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0100","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1259\/bjr\/33076108","article-title":"Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG-PET and early metabolic response to corticosteroid therapy","volume":"80","author":"Aide","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0101","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.0b013e3182684672","article-title":"MRI and PET imaging discordance in neurosarcoidosis","volume":"79","author":"Huang","year":"2012","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0102","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.amjmed.2019.10.041","article-title":"Extrapulmonary sarcoidosis in the orbit, brain, and heart","volume":"133","author":"Park","year":"2020","journal-title":"Am J Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0103","series-title":"PET\/MR Imaging\u202f: A Case-Based Approach","first-page":"265","article-title":"Orbital sarcoidosis","author":"Tank","year":"2018"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0104","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/RLU.0000000000000419","article-title":"Ocular sarcoidosis: does (18)F-FDG-PET\/CT have any role?","volume":"39","author":"Jung","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1573405614666180531111616","article-title":"Hybrid imaging in evaluation of abdominal sarcoidosis","volume":"15","author":"Milojevic","year":"2019","journal-title":"Curr Med Imaging Rev"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0106","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.nephro.2018.11.007","article-title":"18F-FDG positron emission tomography in non-oncological renal pathology: Current indications and perspectives","volume":"15","author":"Hanssen","year":"2019","journal-title":"Nephrol Ther"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0107","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5152\/dir.2014.14210","article-title":"Abdominal sarcoidosis: cross-sectional imaging findings","volume":"21","author":"Gezer","year":"2015","journal-title":"Diagn Interv Radiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0108","first-page":"325","article-title":"Asymptomatic tiny subcutaneous eruptions in a patient with sarcoid neuropathy: the effectiveness of fluorine-18 fluorodeoxyglucose positron emission tomography for targeting safe biopsy sites","volume":"36","author":"Kobayashi","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0109","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s00259-019-04353-0","article-title":"18F-FDG-PET\/CT of sarcoidosis with extensive cutaneous and subcutaneous nodules: the snow leopard sign","volume":"46","author":"Bompard","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0110","doi-asserted-by":"crossref","first-page":"e0949","DOI":"10.1002\/rcr2.949","article-title":"Subcutaneous sarcoidosis (Darier-Roussy sarcoidosis) with extensive disease on positron emission tomography: A case report and review of the literature","volume":"10","author":"Youn","year":"2022","journal-title":"Respirol Case Rep"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0111","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra","year":"2018","journal-title":"Chest"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0112","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1183\/09031936.00141212","article-title":"Sarcoid-like lesion is a frequent benign cause of lymphadenopathy in neoplastic patients","volume":"41","author":"Ravaglia","year":"2013","journal-title":"European Respiratory Journal"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0113","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.crad.2009.03.005","article-title":"Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG-PET\/CT: prevalence and disease pattern","volume":"64","author":"Chowdhury","year":"2009","journal-title":"Clin Radiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0114","article-title":"Another \u201cgreat mimicker\u201d: FDG-PET\/CT imaging findings of sarcoid-like reaction","volume":"1","author":"Kendi","year":"2015","journal-title":"BJR Case Rep"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0115","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0116","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa","year":"2020","journal-title":"Cancer Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0117","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1097\/RLU.0000000000001528","article-title":"Prostate-specific membrane antigen PET\/CT: uptake in lymph nodes with active sarcoidosis","volume":"42","author":"Dias","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0118","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"Journal of Internal Medicine"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0119","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0120","first-page":"143","article-title":"18F-FDG-PET in sarcoidosis: an observational study in 12 patients treated with infliximab","volume":"25","author":"Keijsers","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0121","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1752-699X.2011.00276.x","article-title":"Effect of the TNF-\u03b1 inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET","volume":"6","author":"Milman","year":"2012","journal-title":"Clin Respir J"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0122","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/qjmed\/hcz148","article-title":"Neurosarcoidosis and infliximab therapy monitored by 18FDG-PET\/CT","volume":"112","author":"Rivi\u00e8re","year":"2019","journal-title":"QJM: Int J Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0123","first-page":"123","article-title":"18F-FDG-PET as a predictor of pulmonary function in sarcoidosis","volume":"28","author":"Keijsers","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0124","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13550-019-0505-x","article-title":"Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG-PET\/CT: SUVmax versus total lung glycolysis","volume":"9","author":"Schimmelpennink","year":"2019","journal-title":"EJNMMI Research"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/RLU.0b013e31828731f5","article-title":"Responsiveness of FDG-PET\/CT to treatment of patients with active chronic sarcoidosis","volume":"38","author":"Sobic-Saranovic","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0126","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2967\/jnumed.112.104380","article-title":"The utility of 18F-FDG-PET\/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis","volume":"53","author":"Sobic-Saranovic","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0127","first-page":"372","article-title":"Role of serial F-18 FDG-PET\/CT scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis","volume":"33","author":"Maturu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0128","first-page":"2008","article-title":"Pre-Treatment myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC: Cardiovasc Imag"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.crad.2018.09.015","article-title":"Evaluation of FDG-PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis","volume":"74","author":"Sgard","year":"2019","journal-title":"Clin Radiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0131","article-title":"Utility of FDG-PET and cardiac MRI in diagnosis and monitoring of immunosuppressive treatment in cardiac sarcoidosis","volume":"2","author":"Coulden","year":"2020","journal-title":"Radiol: Cardiothorac Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0132","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0133","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"International Journal of Cardiology"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0134","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/jce.14689","article-title":"Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis: Insights from implantable cardioverter-defibrillator diagnostics","volume":"31","author":"Medor","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0135","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s12350-018-01504-y","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"27","author":"Flores","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0136","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s12350-019-01976-6","article-title":"18F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis","volume":"28","author":"Furuya","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0137","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1148\/rg.2020200068","article-title":"Radionuclide imaging of cardiac amyloidosis and sarcoidosis: roles and characteristics of various tracers","volume":"40","author":"Hotta","year":"2020","journal-title":"RadioGraphics"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0138","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clim.2011.03.015","article-title":"Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation","volume":"140","author":"Rappl","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0139","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jcmg.2019.06.020","article-title":"Imaging cardiac sarcoidosis With FLT-PET compared with FDG\/Perfusion-PET: a prospective pilot study","volume":"12","author":"Martineau","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0141","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2021204714","article-title":"FLT PET\/CT and FDG-PET\/CT of skeletal muscle sarcoidosis","volume":"300","author":"Norikane","year":"2021","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0142","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12149-015-1047-6","article-title":"18F-FDG and 18F-FLT PET\/CT imaging in the characterization of mediastinal lymph nodes","volume":"30","author":"Rayamajhi","year":"2016","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0143","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2362.1999.00498.x","article-title":"Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas","volume":"29","author":"ten Bokum","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0144","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer (68)Ga-DOTANOC PET\/CT and (18)F-FDG-PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0146","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12149-016-1095-6","article-title":"The utility of PET\/CT with 68Ga-DOTATOC in sarcoidosis: comparison with 67Ga-scintigraphy","volume":"30","author":"Nobashi","year":"2016","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0147","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ehf2.12243","article-title":"Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis","volume":"5","author":"Pizarro","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0148","first-page":"OA4649","article-title":"68 Gallium DOTA-NOC PET\/CT as a predictor of disease activity in sarcoidosis","volume":"50","author":"Singh","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0149","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/eurheartj\/ehv278","article-title":"Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography\/computed tomography","volume":"36","author":"Reiter","year":"2015","journal-title":"European Heart Journal"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0150","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/RLU.0000000000003185","article-title":"68Ga-DOTATOC PET for treatment efficacy evaluation of cardiac sarcoidosis","volume":"45","author":"Imperiale","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0151","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/RLU.0000000000000303","article-title":"18)F-choline PET\/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer","volume":"39","author":"Calabria","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0152","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12410-020-9530-4","article-title":"Personalized cardiac imaging with new PET radiotracers","volume":"13","author":"R\u00e9gis","year":"2020","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0153","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00259-021-05341-z","article-title":"Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT\/CT, PET\/CT, and cardiac CT","volume":"48","author":"Slart","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0154","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.121.263598","article-title":"Distinction of lymphoma from sarcoidosis at FDG-PET\/CT - evaluation of radiomic-feature guided machine learning versus human reader performance","author":"Lovinfosse","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0155","doi-asserted-by":"crossref","first-page":"eabi8020","DOI":"10.1126\/sciadv.abi8020","article-title":"Predicting risk of sudden cardiac death in patients with cardiac sarcoidosis using multimodality imaging and personalized heart modeling in a multivariable classifier","volume":"7","author":"Shade","year":"2021","journal-title":"Science Advances"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0156","doi-asserted-by":"crossref","DOI":"10.1007\/s10554-022-02564-5","article-title":"Predicting adverse cardiac events in sarcoidosis: deep learning from automated characterization of regional myocardial remodeling","author":"Lu","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0157","article-title":"Exploring the utility of radiomic feature extraction to improve the diagnostic accuracy of cardiac sarcoidosis using FDG-PET","volume":"9","author":"Mushari","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0158","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.compbiomed.2018.11.008","article-title":"Cardiac sarcoidosis classification with deep convolutional neural network-based features using polar maps","volume":"104","author":"Togo","year":"2019","journal-title":"Comput Biol Med"},{"key":"10.1053\/j.semnuclmed.2022.08.004_bib0159","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2020.11.044","article-title":"Risk and predictors of sudden death in cardiac sarcoidosis: A systematic review and meta-analysis","volume":"328","author":"Franke","year":"2021","journal-title":"Int J Cardiol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299822000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299822000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:59:34Z","timestamp":1762073974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299822000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":159,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0001299822000745"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2022.08.004","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FDG PET\/CT Imaging of Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}